Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119168 · ClinicalTrials.gov registry record · Phase 4
Effect of Simethicone on Screening Colonoscopy
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- Phase 4
- Development phase
- 268
- Enrollment target
NCT03119168 is a Phase 4 study that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 268 participants.
The verdict
NCT03119168, a Phase 4 study, has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 268 participants
- Enrollment target
Study Summary
This study is evaluating the effect of adding a high dose of simethicone to the standard polyethylene glycol preparation for screening colonoscopy in the quality of the preparation , adenoma detection rate and withdrawal times.
Interventions
- DRUG Simethicone Solution
- OTHER Polyethylenglycol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2017-03-15 |
| Est. Completion | 2019-04-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03119168
The ClinicalTrials.gov registry entry for NCT03119168 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Simethicone Solution is the first listed.
NCT03119168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03119168 about?
NCT03119168 is a clinical study titled "Effect of Simethicone on Screening Colonoscopy". This study is evaluating the effect of adding a high dose of simethicone to the standard polyethylene glycol preparation for screening colonoscopy in the quality of the preparation , adenoma detection rate and withdrawal times.
What is the current status of trial NCT03119168?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 268 participants. The study started on 2017-03-15. Estimated completion is 2019-04-10.
What interventions are being tested in trial NCT03119168?
The interventions under investigation include: Simethicone Solution (DRUG), Polyethylenglycol (OTHER).
Who is sponsoring clinical trial NCT03119168?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.